Interojo Inc. (KOSDAQ:119610)
12,730
+40 (0.32%)
Nov 18, 2026, 3:30 PM KST
Interojo Market Cap
Interojo has a market cap or net worth of 143 billion as of November 17, 2026. It is the 24,348th most valuable company in the world and the 960th biggest in South Korea. Its market cap has decreased by 23.93% in one year.
Market Cap
143.00B
Enterprise Value
171.50B
Revenue
124.14B
Global Rank
Country Rank
#960 South Korea
PE Ratio
8.80
ChartMarket Cap Chart
Since July 28, 2010, Interojo's market cap has increased from 44.29B to 143.00B, an increase of 222.88%. That is a compound annual growth rate of 7.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 143.00B | -21.74% |
| Dec 30, 2025 | 182.73B | -53.77% |
| Dec 28, 2023 | 395.31B | 11.81% |
| Dec 29, 2022 | 353.55B | -0.83% |
| Dec 30, 2021 | 356.49B | 45.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.16T |
| Celltrion | 47.40T |
| ALTEOGEN | 11.90T |
| Samsung Epis Holdings | 9.00T |
| BNC KOREA | 147.73B |
| GC Cell | 147.72B |
| Daihan Pharmaceutical | 147.00B |
| NeoImmuneTech | 145.63B |